Article
Cardiomyocyte BRAF is a key signalling intermediate in cardiac hypertrophy in mice
medRxiv · 2022 · Alharbi, H. O.; Hardyman, M. A.; Cull, J. J.; Markou, T.; Cooper, S. T.; Glennon, P. E.; Fuller, S. J.; Sugden, P. H.; Clerk, A.
Key facts
| Title | Cardiomyocyte BRAF is a key signalling intermediate in cardiac hypertrophy in mice |
|---|---|
| First author | Alharbi, H. O.; Hardyman, M. A.; Cull, J. J.; Markou, T.; Cooper, S. T.; Glennon, P. E.; Fuller, S. J.; Sugden, P. H.; Clerk, A. |
| Journal | medRxiv |
| Published | Sep 9, 2022 |
| DOI | 10.1101/2022.09.07.506723 |
| Devices mentioned | K810863 |
| Product codes mentioned | DBM, DXZ, GAW, FTL, GAM, FTM, FZP, GAQ, GCJ |
At a glance
- 1–9 FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1